Harmony Biosciences Holdings: Latest News, Top Stories & Analysis - Page 2 of 2

PLYMOUTH MEETING, PA — Harmony Biosciences (Nasdaq: HRMY) recently unveiled promising data at the annual meeting of the Associated Professional Sleep Societies, “SLEEP 2024.” The data from a Phase 2 …

Harmony Biosciences Expands into Rare Epilepsy Market with Epygenix Therapeutics Acquisition

May 6, 2024May 5, 2024 - by Timothy Alexander

PLYMOUTH MEETING, PA — Harmony Biosciences (Nasdaq: HRMY) announced its recent acquisition of Epygenix Therapeutics, Inc., marking a significant step into the rare epilepsy sector. This acquisition not only broadens …

Rapidly Growing Harmony Biosciences Sees 30% Increase in Net Revenue, Boosts Growth Strategy With Rare Epilepsy Franchise Acquisition

April 30, 2024April 30, 2024 - by Timothy Alexander

PLYMOUTH MEETING, PA — Harmony Biosciences Holdings, Inc. (Nasdaq: HRMY) has released their Q1 2024 report indicating a 30% year-over-year growth in net revenue, sealing the quarter ending March 31, …